FDA Ethics Under Spotlight Of House Oversight Subcommittee Investigation
This article was originally published in The Gray Sheet
Executive Summary
The House Energy & Commerce/Oversight & Investigations Subcommittee is shifting its ongoing ethics investigation toward FDA, Rep. Joe Barton (R-Texas) said May 18 at an NIH ethics hearing